Nimblify Technology Featured as Innovation in Problem Solving at Dpharm: Disruptive Innovations to Advance Clinical Trials Conference

Share Article

Nimblify will present on how to increase protocol quality and compliance through site-supporting technology at the upcoming Dpharm: Disruptive Innovations to Advance Clinical Trials conference September 20 in Boston.

Nimblify Inc., a clinical trials technology company, will be presenting at the 6th Annual Dpharm: Disruptive Innovations to Advance Clinical Trials conference taking place on September 20-21, 2016 at the Fairmont Copley Plaza in Boston, MA. Chaired by Pfizer and Janssen, DPharm is the only event designed for early adopters of new ideas to transform clinical trials for the benefit of patients. For the latest ideas in clinical trials for 21st century drug development, Dpharm gathers out-of-the-box thinkers determined to make clinical trials more affordable and efficient, with higher quality data and a far better experience for patients. 

Nimblify will speak on the “Innovative Sources and Solutions” track of the “Innovation in Problem Solving” portion of DPharm at 2:00 p.m. on Tuesday, September 20. The presentations in this track focus on innovations that solve problems in clinical trials. Nimblify’s Shree Kalluri, Founder and CEO, and Laura Hilty, Vice President, Product Management & Operations, will co-present on the Protocol Calendar Exchange in their talk, “Increasing Protocol Quality and Compliance Through Site-Supporting Technology.”

Instead of requiring each site to manually recreate the protocol calendar or schedule of events in their CTMS from scratch, risking variation in interpretation, the Protocol Calendar Exchange provides one sponsor-approved version that can be downloaded into each site's CTMS. This gives the sponsor more control over the execution of their trial across sites, leading to less deviations, better quality and an accurate and consistent representation of the protocol to help ensure each patient gets his or her planned care.

To schedule a meeting or discussion with Nimblify at Dpharm, email info(at)nimblify(dot)com or visit Nimblify at booth #30.

About Nimblify, Inc. 
Nimblify, Inc. is a clinical trials technology company dedicated to improving trial outcomes by connecting stakeholders in clinical research in innovative ways. Nimblify created Participant Payments, a patient-centric payment system, and hosts Research Resonance Network, a free award-winning benchmarking and metrics comparison tool for sites. Nimblify also developed Research Insights, automated analytics and visualizations for digging deep into clinical research operations, and hosts the Protocol Calendar Exchange, a library of standardized schedule of events that can be used across sites. Spun out of Forte Research Systems in August 2015, Nimblify is a privately held company and is headquartered in Madison, Wis. For more information, please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kristina Lopienski
Follow >
Nimblify, Inc.
Like >
Visit website